近年来,紫杉醇在卵 巢癌治疗中的应用取得了一系列大进展。包括:(1)紫杉醇(泰素)/铂类(TP)优于环磷酰胺/铂类(CP);(2)紫杉醇配伍卡铂与配伍顺铂相比疗效相似,副作用较小;(3)紫杉醇周疗方案对卵巢癌是有效且可耐受的,越来越受到重视。本文对此三方面进行了综述。 In recent years, paclitaxel in the treatment of ovarian cancer has made a series of great progress. Including: (1) paclitaxel (paclitaxel) / platinum (TP) is superior to cyclophosphamide / platinum (CP); (2) paclitaxel compatibility carboplatin compared with the compatibility of cisplatin with similar side effects; ) Weekly paclitaxel regimen for ovarian cancer is effective and tolerable, more and more attention. This article summarizes these three aspects.